GB/T 30915-2014
A-hydroxy polyether polyols
GB/T 30915-2014
2-Hydroxy-6-naphthoic acid
GB/T 30915-2014
Implants for surgery—Hydroxyapatite—Part 1:Ceramic hydroxyapatite
GB/T 30915-2014
Implants for surgery—Hydroxyapatite—Part 2:Coatings of hydroxyapatite
GB/T 30915-2014
Plastics - Octahydroxy polyether polyols
GB/T 30915-2014
Plastics - Trihydroxy polyether polyols
GB/T 30915-2014
Plastics - Tetrahydroxy polyether polyols
GB/T 30915-2014
1-Hydroxyethylidene-1,1-diphosphonate acid
GB/T 30915-2014
Polyhydroxyalkanoates (PHA) by biomanufacturing
GB/T 30915-2014
GB/T 30915-2014
Dihydrogen hexahydroxy platinate
GB/T 30915-2014
Commission Implementing Regulation (EU) 2018/917 of 27 June 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, carvone, chlorpropham, cyazofamid, desmedipham, dimethoate, dimethomorph, diquat, ethephon, ethoprophos, etoxazole, famoxadone, fenamidone, fenamiphos, flumi
GB/T 30915-2014
Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxafl
GB/T 30915-2014
Hydroxycitronellal
GB/T 30915-2014
Hydroxyacetonitrile for industrial use
GB/T 30915-2014
Hydroxyacetonitrile for industrial use Determination of hydroxyacetonitrile,formaldehyde and hydrocyanic acid
GB/T 30915-2014
GB/T 30915-2014
GB/T 30915-2014
Plastics - Di-hydroxyl polyether polyols
GB/T 30915-2014
Plastics - Hex-hydroxyl polyether polyols